Lokmanya Hospitals

  • 020 6666 7708
Facebook Twitter Linkedin Instagram
Book an Appointment

Dr. Sweta Lunkad

Home   >   Dr. Sweta Lunkad

OPD Timings

Tuesday: 11:00 AM – 1:00 PM

Friday: 11:00 AM – 1:00 PM

Wednesday: 11:00 AM – 1:00 PM

Saturday: 11:00 AM – 1:00 PM

Monday: 11:00 AM – 1:00 PM

Thrusday: 11:00 AM – 1:00 PM

Dr. Sweta Lunkad

MBBS, DNB (Medicine), DM ( Clinical Hematology) AIIMS-Delhi Fellowship

  • Medical officer at Jaswali Rural Hospital, Raigad, Maharashtra. Duration:- March 2007 to Feb 2008. ( 11 Months )

  • Post Graduate Student at Jagjivan Ram Western Railway Hospital, Mumbai. Duration: 11st Feb 2008 – 15th Feb 2011 ( 3 years )

  • Physician at Vinoba Bhave Civil Hospital, Silvassa. UT of DNH, Govt. of India. Duration:1st Aug 2011 to 15 Jan 2012.

  • Assistant Professor in Medicine at Bharati Vidhypeeth University Medical College& Bharati Hospital, Pune, from 2nd April 2012 to 10th August 2012.

  • DNB Resident in Sahyadri Hospital,Pune from 10th August 2012 till 15th March 2013

  • Fellowship in Hematology and Bone marrow Transplant unit in BLK Super Specialty Hospital, New Delhi from 1st April 2013 to 30th April 2016.

  • Post graduate – Senior Resident in Department of Clinical Hematology at All India Institute of Medical Sciences (AIIMS) New Delhi from 1st July 2016 – tenure till 1st July 2019

  • MBBS: B.J.Medical College, Pune. DMC Reg. No. 61842 , MMC – 2007/05/0505

  • DNB (Medicine): Jagjeevan Ram railway Hospital, Mumbai. Duration- 11st Feb 2008 – 15th Feb 2011

  • Fellowship in Hematoloy and Bone marrow transplant : Dr.B.L. Kapur Memorial Hospital, New Delhi -5 Duration:- 1st April 2013 – 30th April 2016

  • DM (Clinical Hematology) – AIIMS – New Delhi –Passed 1st July 2016 – tenure upto 1st July 2019

  • “Epidemiology of co existence of Diabetes and hypertension in railway population” as a Post graduate Dissertation. Accepted in 2010

  • Reversible Posterior Leukoencephalopathy Syndrome In A Case Of Adult Onset Still’s Disease With Concurrent Thrombotic Thrombocytopenic Purpura: Response To High Dose Immunoglobulin Infusions; JAPI • November 2012 • VOL. 60

  • Haploidentical Hematopoietic Stem Cell Transplant for Thalassaemia Major Using pre transplant immunosupression and Post Transplant Cyclophosphamide; EBMT16-PH-2014

  • Awarded with “Doctor Of Month” award at Dr.B.L.Kapur Hopsital Delhi in 2015.

  • Presented a poster titeled “Haploidentical hematopoietic stem cell transplant for thalassaemia major using fludarabine – busulphan- thymoglobulin and post transplant cyclophosphamide: early experience”; APBMT2016-ABS-190 at Okinava, Japan.

  • Presented a poster titeled “Bone marrow transplant for recessive dystrophic epidermolysis bullosa: a case report; APBMT2016-ABS-216” at Okinava, Japan.

  • Peripheral Blood Stem Cell Collection on Day 4 Is Feasible and Safe in a Majority of Allogeneic Stem Cell Transplant Donors; 2016 BMT Tandem Meetings

  • Hematopoietic Stem Cell transplant in Elderly Patients: Experience from a tertiary care centre in Northern India; Indian J Hematol Blood Transfus DOI 10.1007/s12288-015-0624-0

  • Day 4 Peripheral Blood Stem Cell Collection in Myeloma Patients is Feasible and and Cost-effective in a Majority of Patients, 15th International Myeloma Workshop Rome, September 23-26, 2015

  • An Unusual Cause of Anemia and Encephalopathy; Mediterr J Hematol Infect Dis www.mjhid.org 2015; 7

  • Renal Involvement in Multiple Myeloma, ISHBT-EHA; Eposter

  • To determine if colonization of gut with carbapenem resistant enterobacteriaceae in surveillance cultures affect the outcome of high risk febrile neutropenic patients”; EHA-1397; EHA 2018

  • Presented a poster titled “ Gut colonization with carbapenem resistant enterobacteriaceae leads to more chemotherapy interruptions and higher mortality in patient with acute leukemia receiving remission induction chemotherapy”; ASH-4002; ASH 2018 at San Diago, USA which was given a travel grant by ICMR (Indian council of Medical research ) New Delhi.

  • “To determine if colonization of gut with carbapenamase resistant enterobacteriaceae in surveillance culture affects the outcome of high risk febrile neutropenic patients” as a DM research project , Submitted to AIIMS in Jan 2019.

  • MBBS

  • DNB(Medicine)

  • DM(Clinical Hematology)

  • AIIMS